CAUSES AND SYMPTOMS OF PULMONARY ARTERIAL HYPERTENSION (PAH) Pulmonary Arterial Hypertension (PAH) can arise from various underlying health conditions or, in some cases, with no identifiable cause.

Merck MRK announced that the phase III HYPERION study evaluating its pulmonary arterial hypertension (“PAH”) drug, Winrevair ...

Pulmonary arterial hypertension, or PAH ... you can get the care you need to ease your symptoms. Your heart pumps blood through your arteries, sending oxygen to all parts of your body.

This condition is known as high blood pressure or hypertension. It’s often called the “silent killer” because most people don ...

Merck’s phase 3 HYPERION study of Winrevair meets primary endpoint in recently diagnosed adults with pulmonary arterial hypertension: Rahway, New Jersey Tuesday, June 24, 2025, ...

Topline results were announced from a phase 3 study evaluating sotatercept-csrk in recently diagnosed adults with pulmonary arterial hypertension (PAH).

June is Men’s Health Month and a perfect time for men to think about and act on ways to better their heart health. Heart ...

New findings from an analysis of the ADVANCE registry support the use of CT angiography as a more central part of the ...

Portal Hypertension Symptoms and Their ComplicationsPortal hypertension is a condition in which increased pressure within the portal vein—an important ... (High Blood Pressure in Lung Arteries) ...